Prevalence of Macrolide Resistance Genes among Staphylococci in Cyprus

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of chemotherapy

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1179/joc.2006.18.5.480PMID 17127223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of Resistance to

  2007cited by this paper
• Investigation of erythromycin and tetracycline resistance genes in methicillin-resistant staphylococci.

  2005cited by this paper
• erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece.

  2004cited by this paper
• Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.

  2002cited by this paper
• Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital.

  2002cited by this paper
• Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.

  2000cited by this paper
• Distribution of Macrolide-Resistance Genes in Staphylococcus aureus Blood-Culture Isolates from Fifteen German University Hospitals

  2000cited by this paper
• Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

  2000cited by this paper
• Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci?

  2000cited by this paper
• Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. The ESPRIT Trial.

  2000cited by this paper
• In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.

  2000cited by this paper
• Correlation between the Resistance Genotype Determined by Multiplex PCR Assays and the Antibiotic Susceptibility Patterns of Staphylococcus aureus andStaphylococcus epidermidis

  2000cited by this paper
• Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.

  1999cited by this paper
• Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

  1999cited by this paper
• Distribution of Genes Encoding Resistance to Macrolides, Lincosamides, and Streptogramins among Staphylococci

  1999cited by this paper
• Characterization of Erythromycin-Resistant Isolates of Staphylococcus aureus Recovered in the United States from 1958 through 1969

  1998cited by this paper
• Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds.

  1997cited by this paper
• Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics

  1996cited by this paper
• Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides

  1996cited by this paper
• erm genes in erythromycin‐resistant Staphylococcus aureus and coagulase‐negative staphylococci

  1995cited by this paper
• Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988

  1995cited by this paper
• Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

  1995cited by this paper
• Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci.

  1993cited by this paper
• Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus.

  1992cited by this paper
• Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics.

  1992cited by this paper
• Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP‐binding transport super‐gene family

  1990cited by this paper
• Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes.

  1988cited by this paper
• Nucleotide sequence of a staphylococcal plasmid gene, vgb, encoding a hydrolase inactivating the B components of virginiamycin-like antibiotics.

  1988cited by this paper
• Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.

  1987cited by this paper

• Analysis of Resistance to Macrolide–Lincosamide–Streptogramin B Among mecA-Positive Staphylococcus Aureus Isolates

  2019cites this paper
• Resistance of Staphylococci to Macrolides-Lincosamides- Streptogramins B (MLSB): Epidemiology and Mechanisms of Resistance

  2018cites this paper
• Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece

  2015cites this paper
• Presence and mechanism of macrolide-lincosamide resistance in Enterococcus columbae strains belonging to the intestinal flora of pigeons

  2004cites this paper